Youngwook Won
Associate Professor
University of North Texas
Department of Biomedical Engineering
Email: Youngwook.Won@unt.edu
Education
-
PhD, Hanyang University - South Korea, 2011
Major: Bioengineering
Professional Memberships
- American Association for Cancer Research. (January 1, 2022 - December 31, 2022).
Teaching
Teaching Experience
- BMEN 4326 - Principles of Biomolecular Engineering, 2 courses.
- BMEN 5326 - Biomolecular Engineering, 4 courses.
- BMEN 5327 - Immuno engineering, 2 courses.
- BMEN 5810 - Topics in Biomedical Engineering, 1 course.
- BMEN 5900 - Special Problems in Biomedical Engineering, 5 courses.
- BMEN 6910 - Individual Research, 2 courses.
- BMEN 6950 - Biomedical Engineering Doctoral Dissertation, 1 course.
University of North Texas
Directed Student Learning
- Supervised Research, Biomedical Engineering. (January 1, 2023).
- Dissertation Committee Member, Biomedical Engineering. (December 8, 2023).
- Master's Thesis Committee Member, Biomedical Engineering. (October 31, 2023).
Research
Published Intellectual Contributions
- Lee, C., Yi, J., Park, J., Ahn, B., Won, Y., Jeon, J., Lee, B., Cho, W., Park, J. (2024). Hedgehog signalling is involved in acquired resistance to KRASG12C inhibitors in lung cancer cells. https://www.nature.com/articles/s41419-024-06436-9#:~:text=Together%2C%20these%20findings%20demonstrate%20the,resistance%20to%20KRASG12C%20inhibitors.
- Lee, U., Park, S., Ju, S., Lee, S., Kim, B., Ahn, B., Yi, J., Park, J., Won, Y., Han, I., Lee, B., Cho, W., Park, J. (2023). DRG2 in macrophages is crucial for initial inflammatory response and protection against Listeria monocytogenes infection. https://www.sciencedirect.com/science/article/abs/pii/S152166162300582X?via%3Dihub
Journal Article
Media Contributions
- "Texas Life Science Forum," (November 7, 2023).
- "Hwasoon International Immunotherapy and Vaccine Forum," (November 17, 2023).
Internet
Newspaper
Contracts, Grants, Sponsored Research
- Won, Y. (Principal), "Targeted Systemic Delivery of SDF-1 DNA for the Treatment of Chronic Heart Disease," sponsored by NIH, Federal, $41831 Funded. (2023 - 2024).
- Won, Y. (Principal), "Feasibility test of an injectable form of immune modulator," sponsored by Thunder Bay Therapeutics, Private, $100000 Funded. (2022 - 2023).
Grant - Research
Service
University Service
- Committee Member, Conflict of Interest. (August 1, 2023 - Present).
Professional Service
- Reviewer, Ad Hoc Reviewer, NIH. Washington DC, Washington DC. (October 6, 2022 - October 7, 2022).
Consulting
- For Profit Organization, Bielle Cosmetics, Pasadena, CA, United States of America. (January 1, 2023 - December 31, 2023).